Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. The Company develops and commercializes products both within Fortress and through certain of its subsidiary companies, also known as Fortress Companies. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities. 

Type
Public
HQ
New York, US
Founded
2006
Size (employees)
45 (est)
Fortress Biotech was founded in 2006 and is headquartered in New York, US
Report incorrect company information

Fortress Biotech Office Locations

Fortress Biotech has an office in New York
New York, US (HQ)
2 Gansevoort St
Show all (1)
Report incorrect company information

Fortress Biotech Financials and Metrics

Fortress Biotech Revenue

Fortress Biotech's revenue was reported to be $16.48 m in FY, 2016 which is a 1809.6% increase from the previous period.
USD

Revenue (Q2, 2018)

119.3 m

Net income (Q2, 2018)

(73.9 m)

EBIT (Q2, 2018)

179.3 m

Market capitalization (14-Aug-2018)

109.2 m

Closing stock price (14-Aug-2018)

2

Cash (30-Jun-2018)

98.6 m
Fortress Biotech's current market capitalization is $109.2 m.
Annual
USDFY, 2015FY, 2016

Revenue

863 k16.5 m

Revenue growth, %

1810%

Cost of goods sold

790 k

Gross profit

15.7 m
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Revenue

383 k2.2 m975 k44.7 m55.4 m119.3 m

Sales and marketing expense

24.5 m25.6 m57 m

General and administrative expense

2.7 m3.5 m3.8 m7.1 m7.9 m8.6 m8.9 m8 m10.8 m20.9 m

R&D expense

1.6 m1.6 m2.4 m9.1 m7.7 m6.3 m7.3 m8.4 m12 k42.4 m
Annual
USDFY, 2015FY, 2016

Cash

98.2 m88.3 m

Accounts Receivable

1.8 m

Inventories

1.6 m203 k

Current Assets

99.8 m109.6 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Cash

75.8 m71.6 m48.9 m41 m25.6 m81.4 m71.3 m82.5 m134 m124 m98.6 m

Accounts Receivable

967 k5 m1.4 m8.3 m5.3 m

Inventories

100 k123 k204 k222 k299 k

Current Assets

76.5 m72.1 m69.6 m62 m66.6 m84.3 m76.6 m98.6 m151.8 m200.2 m171.5 m
Annual
USDFY, 2015FY, 2016

Net Income

(53.9 m)(71.3 m)

Depreciation and Amortization

545 k

Inventories

(895 k)(203 k)

Accounts Payable

5.9 m5.4 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(4.6 m)(12.5 m)(6.4 m)(19.9 m)(16.6 m)(16.4 m)(17 m)(14.6 m)(38.2 m)(73.9 m)

Depreciation and Amortization

506 k365 k831 k

Inventories

100 k123 k204 k(51 k)(128 k)

Accounts Payable

331 k333 k664 k583 k1.3 m2.3 m5.1 m21.8 m24.9 m8.3 m1.2 m
USDY, 2018

Financial Leverage

2.5 x
Show all financial metrics
Report incorrect company information

Fortress Biotech Online and Social Media Presence

Embed Graph
Report incorrect company information

Fortress Biotech News and Updates

Report incorrect company information

Fortress Biotech Company Life and Culture

Report incorrect company information